title: Lack of effect of piperonyl butoxide on unscheduled DNA synthesis in precision-cut human liver slices.
abstract: In this study the effect of piperonyl butoxide (PBO) on unscheduled DNA synthesis in precision-cut human liver slices has been examined. Liver slices prepared from tissue samples from five human donors were cultured in medium containing [3H]thymidine and 0-2.5 mM PBO using a dynamic organ culture system. After 24 h the liver slices were processed for autoradiographic examination of UDS. As positive controls, liver slices were also cultured with three known genotoxic agents, namely 2-acetylaminofluorene (2-AAF), aflatoxin B1 (AFB1) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). UDS was quantified as the net grain count in centrilobular hepatocytes and as the percentage of centrilobular hepatocyte nuclei with > 5 and > 10 net grains. Compared to control liver slice cultures PBO had no effect on UDS. In contrast, treatment with 0.02 and 0.05 mM 2-AAF, 0.002 and 0.02 mM AFB1 and 0.005 and 0.05 mM PhIP produced significant increases in net grain counts of centrilobular hepatocytes. The greatest induction of UDS was observed in liver slices treated with 0.05 mM PhIP. Treatment with 2-AAF, AFB1 and PhIP also produced increases in the number of centrilobular hepatocyte nuclei with > 5 and > 10 net grains. At the concentrations examined neither PBO, 2-AAF nor PhIP had any significant effect on replicative DNA synthesis in 24 h cultured human liver slices. In cultured liver slices treated with 0.02, but not 0.002, mM AFB1 a significant reduction in the rate of replicative DNA synthesis was observed. These results demonstrate that PBO does not induce UDS in cultured human liver slices. However, all three positive control compounds produced marked significant increases in UDS, thus confirming the functional viability of the human liver slice preparations used in this study. In conclusion, these results provide further evidence that PBO is a non-genotoxic agent which does not damage DNA in human liver.
authors.affiliation: BIBRA International, Carshalton, Surrey, UK.
authors.forename: J A
authors.initials: JA
authors.lastname: Beamand
authors.forename: R J
authors.initials: RJ
authors.lastname: Price
authors.forename: J C
authors.initials: JC
authors.lastname: Phillips
authors.forename: W H
authors.initials: WH
authors.lastname: Butler
authors.forename: G D
authors.initials: GD
authors.lastname: Jones
authors.forename: T G
authors.initials: TG
authors.lastname: Osimitz
authors.forename: K L
authors.initials: KL
authors.lastname: Gabriel
authors.forename: F J
authors.initials: FJ
authors.lastname: Preiss
authors.forename: B G
authors.initials: BG
authors.lastname: Lake
mesh_terms: D004260:DNA Repair; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D009153:Mutagens / Q000633:toxicity; D009924:Organ Culture Techniques; D010882:Piperonyl Butoxide / Q000633:toxicity*
chemical_list: D009153:Mutagens; D010882:Piperonyl Butoxide